Table 2: Effect of ARBs and antidiabetic agents on lipid profile during 3 consecutive follow ups.
Parameters | TC (mg/dl) | TG (mg/dl) | LDL (mg/dl) | HDL (mg/dl) | |||||||||
Antihypertensive agents | Antidiabetic agents | 1st | 2nd | 3rd | 1st | 2nd | 3rd | 1st | 2nd | 3rd | 1st | 2nd | 3rd |
ARBs | Insulin | 172.8 ± 13.3 | 168.7 ± 9.3 | 183.5 ± 7.3 | 141.1 ± 15.7 | 160.9 ± 24.4 | 187.2 ± 38.7 | 112.9 ± 11.2 | 105.5 ± 6.4 | 112.1 ± 6.3 | 46.2a ± 3.5 | 37.7 ± 2.6 | 56.0 ± 11.9 |
Biguanide | 165.8 ± 10.3 | 171.8 ± 13.1 | 165.3 ± 11.2 | 170.8 ± 44 | 131 ± 18.8 | 131.4 ± 38.2 | 96.2 ± 12 | 106.3 ± 8.1 | 100.6 ± 9.9 | 36.5b ± 2.2 | 38.8 ± 3.6 | 43.0 ± 5.0 | |
Biguanide + DPP-4I | 152 ± 14.8 | 159.2 ± 11.2 | 155.4 ± 9.8 | 180.1 ± 29.7 | 153.3 ± 28.5 | 141.7 ± 24.4 | 94.1 ± 10.7 | 99.3 ± 8.7 | 91.9 ± 7.7 | 42 ± 2.3 | 43.7 ± 3.3 | 39.4 ± 3.6 |
Values represent mean ± SE.
Different Small alphabetical letter in the same column within the same parameters are significant at P < 0.05 (Two way ANOVA).